HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Pharmaceutical Product Development and Manufacturing
- Manufacturing equipment and technologies
- New manufacturing techniques
- Industrial and Physical Pharmacy
- Pharmaceutical Technology
- Pharmaceutical Packaging
Pharmaceutical Product Development is a system of designing, analyzing, and controlling manufacturing through timely measurements of critical quality and performance of raw and in-process materials and processes with the goal of verifying final product quality.
New product development includes:
- Molecule identification,
- Molecule screening,
- Sourcing of raw material,
- Pilot batch manufacturing,
- Marketing strategy development,
- Test marketing/Clinical trial/user trial, and
- Commercialization
Pharmaceutical manufacturing is a process where the synthesis of pharmaceutical drugs is part of the pharmaceutical industry. The drug manufacturing process can be broken down into a series of unit operations, such as
- Milling
- Granulation
- Coating
- Tablet pressing
- Blending
- Encapsulation
- Coating and drying
Committee Members
A C Matin
Stanford University, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Consolato M Sergi
University of Ottawa, Canada PDDS 2024 Speakers
Miroslav Radenkovic
University of Belgrade, Serbia
A C Matin
Stanford University, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Andreas M Papas
Antares Health Products, United States
Consolato M Sergi
University of Ottawa, Canada
Thomas Ullrich
Novartis Biomedical Research, SwitzerlandSubmit your abstract Today
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Personalized and precision medicine (PPM) as a unique healthcare model to be set up via biodesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Clinical pharmacology of aprocitentan (an endothelin receptor antagonist) – The most recent quality progress in treatment of resistant hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Clinical decision making in advanced and metastatic breast cancer cases between PARP inhibitors and CDK4/6 inhibitors
Priya Hays, Hays Documentation Specialists, LLC, United States
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Novel nano drug platform for pharmacologically inducing therapeutic hypothermia (TH) after traumatic brain injury (TBI)
Jorge David Tovar Castro, University of Miami Miller School of Medicine, United States
Title : Global drug development - Trends, challenges and opportunities
Gurpreet Singh, IQVIA, United Kingdom
Title : Drug design for the development of long-acting injectables
Thomas Ullrich, Novartis Biomedical Research, Switzerland
Title : Synthesis and properties of new unique heterocyclic systems: Pyrido[3'',2'':4',5']furo(thieno)[3',2':4,5]pyrimido[2,1-f][1,2,4]triazines
Anush, National Academy of Sciences of the Republic of Armenia, Armenia
Title : Development and evaluation of prolonged-release dutasteride transdermal delivery system
Shereen M. Assaf, Jordan University of Science and Technology, Jordan